Lomonitinib
3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydroisoquinolin-7-yl)pyrazolo[4,5-c]quinoline
Molecular Identity
Lomonitinib
3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydroisoquinolin-7-yl)pyrazolo[4,5-c]quinoline
PubChem CID: 171775678
2D Structure
Properties
C27H24N4O2
Molecular Formula
436.50
Molecular Weight
g/mol
436.1899
Exact Mass
Da
4.5
XLogP
Drug-like (Lipinski: < 5)
61.2
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
5
H-Bond Acceptors
664
Complexity
SMILES
Canonical SMILES
SMILES: COC1=C(C=C(C=C1)C2=NN(C3=C2C=NC4=CC=CC=C43)C5=CC6=C(CCNC6)C=C5)OCIsomeric SMILES
SMILES: COC1=C(C=C(C=C1)C2=NN(C3=C2C=NC4=CC=CC=C43)C5=CC6=C(CCNC6)C=C5)OCSynonyms(20)
Lomonitinib2923221-56-9lomonitinib [INN]U4DPU7W7QUorb2944628SCHEMBL29254428SCHEMBL30951540GTPL13750BDBM712322EX-A16112HY-168982US20250011319, Compound 1.31ZE46-0134T2054703-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydroisoquinolin-7-yl)pyrazolo[4,3-c]quinoline
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lomonitinib
Loading drug network...